Characterization of spontaneous, in vitro-selected, rifampin-resistant mutants of Mycobacterium tuberculosis strain H37Rv

被引:63
作者
Morlock, GP [1 ]
Plikaytis, BB [1 ]
Crawford, JT [1 ]
机构
[1] Ctr Dis Control & Prevent, TB Mycobacteriol Branch, Natl Ctr Infect Dis, Atlanta, GA 30333 USA
关键词
D O I
10.1128/AAC.44.12.3298-3301.2000
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Resistance to rifampin in Mycobacterium tuberculosis results from mutations in the gene coding for the beta subunit of RNA polymerase (rpoB), At least 95% of rifampin-resistant isolates have mutations in rpoB, and the mutations are clustered in a small region. About 40 distinct point mutations and in-frame insertions and deletions in rpoB have been identified, but point mutations in two codons, those coding for Ser,,, and His,,,, are seen in about 70% of rifampin-resistant clinical isolates, with Ser(531)-t-Leu (TCG-to TGG) mutations being by far the most common. To explore this phenomenon, we isolated independent, spontaneous, rifampin-resistant mutant versions of well-characterized M, tuberculosis laboratory strain H37Rv by plating 100 separate cultures, derived from a single low-density inoculum, onto rifampin containing medium. Rifampin-resistant mutants were obtained from 64 of these cultures. Although we anticipated that the various point mutations would occur with approximately equal frequencies, sequencing the rpoB gene from one colony per plate revealed that 39 (60.9%) were Ser(531) to Leu. We conclude that, for unknown reasons, the associated rpoB mutation occurs at a substantially higher rate than other rpoB mutations. This higher mutation rate may contribute to the high percentage of this mutation seen in clinical isolates.
引用
收藏
页码:3298 / 3301
页数:4
相关论文
共 18 条
  • [1] Physiological cost of rifampin resistance induced in vitro in Mycobacterium tuberculosis
    Billington, OJ
    McHugh, TD
    Gillespie, SH
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (08) : 1866 - 1869
  • [2] Detection of rifampin resistance among isolates of Mycobacterium tuberculosis from Mozambique
    Caugant, DA
    Sandven, P
    Eng, J
    Jeque, JT
    Tonjum, T
    [J]. MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE, 1995, 1 (04): : 321 - 326
  • [4] Escalante P., 1998, Tubercle and Lung Disease, V79, P111, DOI 10.1054/tuld.1998.0013
  • [5] Gonzalez N., 1999, Tubercle and Lung Disease, V79, P187, DOI 10.1054/tuld.1998.0195
  • [6] IMPLICATIONS OF MULTIDRUG-RESISTANCE FOR THE FUTURE OF SHORT-COURSE CHEMOTHERAPY OF TUBERCULOSIS - A MOLECULAR STUDY
    HEYM, B
    HONORE, N
    TRUFFOTPERNOT, C
    BANERJEE, A
    SCHURRA, C
    JACOBS, WR
    VANEMBDEN, JD
    GROSSET, JH
    COLE, ST
    [J]. LANCET, 1994, 344 (8918) : 293 - 298
  • [7] CHARACTERIZATION BY AUTOMATED DNA-SEQUENCING OF MUTATIONS IN THE GENE (RPOB) ENCODING THE RNA-POLYMERASE BETA-SUBUNIT IN RIFAMPIN-RESISTANT MYCOBACTERIUM-TUBERCULOSIS STRAINS FROM NEW-YORK-CITY AND TEXAS
    KAPUR, V
    LI, LL
    IORDANESCU, S
    HAMRICK, MR
    WANGER, A
    KREISWIRTH, BN
    MUSSER, JM
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (04) : 1095 - 1098
  • [8] Kent P. T., 1985, PUBLIC HLTH MYCOBACT
  • [9] Luria SE, 1943, GENETICS, V28, P491
  • [10] A Ser315Thr substitution in KatG is predominant in genetically heterogeneous multidrug-resistant Mycobacterium tuberculosis isolates originating from the St. Petersburg area in Russia
    Marttila, HJ
    Soini, H
    Eerola, E
    Vyshnevskaya, E
    Vyshnevskiy, BI
    Otten, TF
    Vasilyef, AV
    Viljanen, MK
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (09) : 2443 - 2445